πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

2,762 results for β€œCTI” Clear

  1. Varenicline, then placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Addiction

    phase 1 small molecule completed

    1 trial

  2. Venezuelan Equine Encephalitis DNA Vaccine

    United Therapeutics Europe Ltd

    Vaccine Reaction

    phase 1 small molecule active

    1 trial

  3. Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

    Istituto Gentili S.r.l.

    Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.

    phase 1 other active

    1 trial

  4. Visual Sputum Suctioning System

    The First People's Hospital of Lianyungang

    Ineffective Airway Clearance

    phase 1 other active

    1 trial

  5. Vyxeos 44 MG / 100 MG Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Relapsed Pediatric AML

    phase 1 small molecule active

    1 trial

  6. WGc-0201 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  7. XTL-2125

    XTL BIOPHARMACEUTICALS LTD

    Chronic Hepatitis C Virus Infection

    phase 1 small molecule terminated

    1 trial

  8. YTS104 Cells injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed or Refractory Multiple Myeloma

    phase 1 mab active

    1 trial

  9. YTS109 cell injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis (LN)

    phase 1 small molecule active

    1 trial

  10. ZB001 for injection

    Zenas BioPharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. ZB001 for injection

    Zenas BioPharma

    Thyroid Eye Disease

    phase 1 small molecule completed

    1 trial

  12. ZG0895 Hydrochloride for Injection

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  13. Ziftomenib, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Solu-Cortef Powder for Solution for Injection or Infusion 100 mg

    AXIM BIOTECHNOLOGIES, INC.

    Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Acute Lymphocytic Leukemia

    phase 1 small molecule active

    1 trial

  14. [11C]CPPC Injection

    Chongqing Precision Biotech Co., Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule terminated

    1 trial

  15. [14C]-GSK961081 solution for IV infusion

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    1 trial

  16. [203Pb]VMT-Ξ±-NET

    Perspective Therapeutics

    Neuroendocrine Tumor Grade 2

    phase 1 small molecule active

    1 trial

  17. [203Pb]VMT01

    Perspective Therapeutics

    Melanoma (Skin)

    phase 1 small molecule completed

    1 trial

  18. [212Pb] VMT-Ξ±-NET

    Perspective Therapeutics

    Neuroendocrine Tumors

    phase 1 small molecule active

    1 trial

  19. aerosol inhaled amikacin

    The First People's Hospital of Lianyungang

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 1 small molecule completed

    1 trial

  20. an inactivated whole virion H5N1 vaccine, adjuvanted

    Sinovac Research and Development Co.,

    Influenza

    phase 1 mab completed

    1 trial

  21. autologous cell-based delivery

    Regeneron Ireland Designated Activity Company (DAC)

    Hypoplastic Left Heart Syndrome

    phase 1 mab completed

    1 trial

  22. belapectin

    GALECTIN THERAPEUTICS INC

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  23. d-cycloserine

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    phase 1 small molecule active

    1 trial

  24. dexlansoprazole injection

    The First People's Hospital of Lianyungang

    Safety Issues

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources